Found: 12
Select item for more details and to access through your institution.
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies.
- Published in:
- Acta Pharmacologica Sinica, 2015, v. 36, n. 10, p. 1170, doi. 10.1038/aps.2015.71
- By:
- Publication type:
- Article
Toward rapamycin analog (rapalog)-based precision cancer therapy.
- Published in:
- Acta Pharmacologica Sinica, 2015, v. 36, n. 10, p. 1163, doi. 10.1038/aps.2015.68
- By:
- Publication type:
- Article
A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.
- Published in:
- Acta Pharmacologica Sinica, 2013, v. 34, n. 9, p. 1201, doi. 10.1038/aps.2013.81
- By:
- Publication type:
- Article
Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Letter
The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1276, doi. 10.1007/s10637-010-9481-8
- By:
- Publication type:
- Article
PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 130, n. 1, p. 85, doi. 10.1007/s10549-010-1302-4
- By:
- Publication type:
- Article
Thirteen‐exon‐motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases.
- Published in:
- Nucleic Acids Research, 2004, v. 32, n. 7, p. 2087, doi. 10.1093/nar/gkh525
- By:
- Publication type:
- Article
Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond.
- Published in:
- Medicinal Research Reviews, 2015, v. 35, n. 4, p. 720, doi. 10.1002/med.21341
- By:
- Publication type:
- Article
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
- Published in:
- Molecular & Cellular Biochemistry, 2012, v. 360, n. 1/2, p. 329, doi. 10.1007/s11010-011-1072-2
- By:
- Publication type:
- Article
Membrane metallo‐endopeptidase mediates cellular senescence induced by oncogenic PIK3CA<sup>H1047R</sup> accompanied with pro‐tumorigenic secretome.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 817, doi. 10.1002/ijc.32153
- By:
- Publication type:
- Article
HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 10, p. 2462, doi. 10.1002/ijc.28880
- By:
- Publication type:
- Article
Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03370-4
- By:
- Publication type:
- Article